BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37802313)

  • 1. Unlatching of the stem domains in the Staphylococcus aureus pore-forming leukocidin LukAB influences toxin oligomerization.
    Ilmain JK; Perelman SS; Panepinto MC; Irnov I; Coudray N; Samhadaneh N; Pironti A; Ueberheide B; Ekiert DC; Bhabha G; Torres VJ
    J Biol Chem; 2023 Dec; 299(12):105321. PubMed ID: 37802313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition.
    DuMont AL; Yoong P; Liu X; Day CJ; Chumbler NM; James DB; Alonzo F; Bode NJ; Lacy DB; Jennings MP; Torres VJ
    Infect Immun; 2014 Mar; 82(3):1268-76. PubMed ID: 24379286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1.
    DuMont AL; Yoong P; Day CJ; Alonzo F; McDonald WH; Jennings MP; Torres VJ
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10794-9. PubMed ID: 23754403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.
    Scherr TD; Hanke ML; Huang O; James DB; Horswill AR; Bayles KW; Fey PD; Torres VJ; Kielian T
    mBio; 2015 Aug; 6(4):. PubMed ID: 26307164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation of staphylococcal LukAB toxin determines receptor tropism.
    Perelman SS; James DBA; Boguslawski KM; Nelson CW; Ilmain JK; Zwack EE; Prescott RA; Mohamed A; Tam K; Chan R; Narechania A; Pawline MB; Vozhilla N; Moustafa AM; Kim SY; Dittmann M; Ekiert DC; Bhabha G; Shopsin B; Planet PJ; Koralov SB; Torres VJ
    Nat Microbiol; 2021 Jun; 6(6):731-745. PubMed ID: 33875847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular.
    Melehani JH; James DB; DuMont AL; Torres VJ; Duncan JA
    PLoS Pathog; 2015 Jun; 11(6):e1004970. PubMed ID: 26069969
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Berends ETM; Zheng X; Zwack EE; Ménager MM; Cammer M; Shopsin B; Torres VJ
    mBio; 2019 Jan; 10(1):. PubMed ID: 30602580
    [No Abstract]   [Full Text] [Related]  

  • 8. Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity.
    Tromp AT; Van Gent M; Jansen JP; Scheepmaker LM; Velthuizen A; De Haas CJC; Van Kessel KPM; Bardoel BW; Boettcher M; McManus MT; Van Strijp JAG; Lebbink RJ; Haas PA; Spaan AN
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32041354
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Savin A; Anderson EE; Dyzenhaus S; Podkowik M; Shopsin B; Pironti A; Torres VJ
    Infect Immun; 2024 Feb; 92(2):e0052623. PubMed ID: 38235972
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.
    Reyes-Robles T; Lubkin A; Alonzo F; Lacy DB; Torres VJ
    EMBO Rep; 2016 Mar; 17(3):428-40. PubMed ID: 26882549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of Toxoid Vaccine Candidates for
    Kailasan S; Kort T; Mukherjee I; Liao GC; Kanipakala T; Williston N; Ganjbaksh N; Venkatasubramaniam A; Holtsberg FW; Karauzum H; Adhikari RP; Aman MJ
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31207937
    [No Abstract]   [Full Text] [Related]  

  • 12. The cell envelope of Staphylococcus aureus selectively controls the sorting of virulence factors.
    Zheng X; Marsman G; Lacey KA; Chapman JR; Goosmann C; Ueberheide BM; Torres VJ
    Nat Commun; 2021 Oct; 12(1):6193. PubMed ID: 34702812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
    Badarau A; Trstenjak N; Nagy E
    Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).
    Wood JB; Jones LS; Soper NR; Nagarsheth M; Creech CB; Thomsen IP
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophages.
    Chow SH; Deo P; Yeung ATY; Kostoulias XP; Jeon Y; Gao ML; Seidi A; Olivier FAB; Sridhar S; Nethercott C; Cameron D; Robertson AAB; Robert R; Mackay CR; Traven A; Jin ZB; Hale C; Dougan G; Peleg AY; Naderer T
    J Leukoc Biol; 2020 Sep; 108(3):967-981. PubMed ID: 32531864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?
    Vandenesch F; Lina G; Henry T
    Front Cell Infect Microbiol; 2012; 2():12. PubMed ID: 22919604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.
    Thomsen IP; Sapparapu G; James DBA; Cassat JE; Nagarsheth M; Kose N; Putnam N; Boguslawski KM; Jones LS; Wood JB; Creech CB; Torres VJ; Crowe JE
    J Infect Dis; 2017 Apr; 215(7):1124-1131. PubMed ID: 28186295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.
    Badarau A; Rouha H; Malafa S; Logan DT; Håkansson M; Stulik L; Dolezilkova I; Teubenbacher A; Gross K; Maierhofer B; Weber S; Jägerhofer M; Hoffman D; Nagy E
    J Biol Chem; 2015 Jan; 290(1):142-56. PubMed ID: 25371205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity.
    Trstenjak N; Milić D; Graewert MA; Rouha H; Svergun D; Djinović-Carugo K; Nagy E; Badarau A
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):317-327. PubMed ID: 31852826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
    Seilie ES; Bubeck Wardenburg J
    Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.